Firocoxib

Firocoxib

Systematic (IUPAC) name
3-(Cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one
Clinical data
Trade names	Equioxx; Previcox
AHFS/Drugs.com	International Drug Names
Legal status	AU: S4 (Prescription only) UK: POM (Prescription only) US: ℞-only Veterinary use only
Routes of administration	Oral
Identifiers
CAS Number	189954-96-9
ATCvet code	QM01AH90 (WHO)
PubChem	CID: 208910
ChemSpider	181008 Y
UNII	Y6V2W4S4WT Y
KEGG	D03712 Y
ChEBI	CHEBI:76136
ChEMBL	CHEMBL69998 Y
Chemical data
Formula	C17H20O5S
Molecular mass	336.402 g/mol
SMILES O=C2OC(C(=C2\OCC1CC1)\c3ccc(cc3)S(=O)(=O)C)(C)C
InChI InChI=1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3 Y Key:FULAPETWGIGNMT-UHFFFAOYSA-N Y
(verify)

Firocoxib (INN; brand names Equioxx and Previcox) is a non-steroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, currently approved for use in dogs and horses. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use in human medicine.